88 Energy Sells Texas Assets and Reports Strategic Updates in Half-Year Results
88 Energy sells Texas assets to sharpen focus on Alaska's Project Phoenix, with a fully funded horizontal test planned for mid-2026.
This article covers information on 88 Energy Limited.
LON:88ETexas divestment and Alaskan focus: what 88 Energy just told the market
88 Energy’s half-year to 30 June 2025 is all about sharpening the portfolio. The company has agreed to sell its Texas production interests, doubled down on Alaska with a fully carried horizontal test at Project Phoenix, and pushed Project Leonis and Namibia forward without reaching for the equity tap.
Below I break down the key project updates and the numbers, and give a view on what matters for shareholders.
Project Phoenix – fully carried to a mid-2026 horizontal test
Phoenix is an advanced conventional oil project on Alaska’s North Slope. The Hickory-1 discovery well confirmed light oil in 2024 from the SMD-B and Upper SFS targets and underpins a horizontal production test plan.
- Total 2C Contingent Resources: 239 MMBOE net to 88E. “2C” means the mid-case estimate of discovered, but not yet commercial, resources.
- Farm-out signed with Burgundy Xploration LLC in February 2025. “Farm-out” means 88E trades a slice of working interest (WI) for funding.
- Phase 1: Burgundy to fund US$29 million of the CY25/26 work programme, including a horizontal well and production testing scheduled for mid-2026. 88E is fully carried and would hold 35% WI after Phase 1.
- Phase 2 (subject to Phase 1 success): up
Related
Keep reading
Investing
Ten Technologies Preliminary Results 2026: Record EBITDA and Member Growth
Ten Technologies delivered record 2026 results as active members rose 23% and adjusted EBITDA increased 10% to £16.1 million.
JoshuaNovember 11, 2026
Investing
Winvia Entertainment completes The Online Giveaway Guys acquisition
Winvia Entertainment has completed its purchase of The Online Giveaway Guys' business and key assets, excluding liabilities, cash and receivables.
JoshuaNovember 10, 2026
Investing
RUA Life Sciences reaches positive adjusted EBITDA as Structural Heart spin-out reshapes the group
RUA Life Sciences expects £5.5 million revenue and £0.3 million adjusted EBITDA, but ABISS weakness and lower cash warrant attention.
JoshuaNovember 9, 2026
Last updated
Category
InvestingLikes
Star Rating
No ratings yet
Comments
No comments yet - start the conversation.